Fei Xiao

770 total citations
58 papers, 513 citations indexed

About

Fei Xiao is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Fei Xiao has authored 58 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Immunology. Recurrent topics in Fei Xiao's work include Immune Cell Function and Interaction (8 papers), Computational Drug Discovery Methods (4 papers) and Bioinformatics and Genomic Networks (4 papers). Fei Xiao is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Computational Drug Discovery Methods (4 papers) and Bioinformatics and Genomic Networks (4 papers). Fei Xiao collaborates with scholars based in China, United States and Thailand. Fei Xiao's co-authors include Guang Hu, Yaping Guo, Yang Li, Kangnian Fan, Min Hu, Wenning Wang, Qinfei Ke, Wanwipa Vongsangnak, Yuqian Li and Jia Zhou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Fei Xiao

52 papers receiving 510 citations

Peers

Countries citing papers authored by Fei Xiao

Since Specialization

Citations

This map shows the geographic impact of Fei Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Xiao more than expected).

Fields of papers citing papers by Fei Xiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Xiao. The network helps show where Fei Xiao may publish in the future.

Co-authorship network of co-authors of Fei Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Xiao. A scholar is included among the top collaborators of Fei Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Xiao. Fei Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Perturbation response scanning of drug-target networks: Drug repurposing for multiple sclerosis 2025 ·Journal of Pharmaceutical Analysis ·(unknown), (unknown), Qi Li, Bin Yang, Xing Xu, Yu Zhu, (unknown), Yilun Qi, Fei Xiao, Wenying Yan, Zhongjie Liang, Qifei Cong, Guang Hu	2
2	Beyond Dimerization: Harnessing Tetrameric Coiled‐Coils for Nanostructure Assembly 2024 ·Angewandte Chemie International Edition ·(unknown), (unknown), Jana Aupič, Žiga Strmšek, Ajasja Ljubetič, Fei Xiao, Guang Hu, Chuan Liu, Florian Beck, Philipp S. Erdmann, Roman Jerala	1
3	Intestinal activating transcription factor 4 regulates stress-related behavioral alterations via paraventricular thalamus in male mice 2023 ·Proceedings of the National Academy of Sciences ·(unknown), Ziheng Zhou, (unknown), (unknown), Liang Chen, Leilei Fang, (unknown), (unknown), Xiaoxue Jiang, Kan Liu, Fei Xiao, (unknown), Shanghai Chen, Zhanju Liu, Yousheng Shu, Feifan Guo	9
4	Distinct mechanisms of dysfunctional antigen‐presenting DCs and monocytes by single‐cell sequencing in multiple myeloma 2023 ·Cancer Science ·(unknown), Jing Xiang, Mengping Chen, (unknown), (unknown), Xiaofeng Han, Xiaotong Chen, Junying Wang, Fei Xiao, Jia Liu, Hua Li, Honghui Huang, Jian Hou	13
5	Dynamic single-cell RNA-seq analysis reveals distinct tumor program associated with microenvironmental remodeling and drug sensitivity in multiple myeloma 2023 ·Cell & Bioscience ·Mengping Chen, (unknown), Xin Li, Jing Xiang, Xiaotong Chen, (unknown), Xiaofeng Han, (unknown), Fei Xiao, Jia Liu, Honghui Huang, Hua Li, Junling Liu, Jian Hou	8
6	Single-cell analysis of graft-infiltrating host cells identifies caspase-1 as a potential therapeutic target for heart transplant rejection 2023 ·Frontiers in Immunology ·Zhichao Wu, Jialiang Liang, Shuoji Zhu, Nanbo Liu, Mingyi Zhao, Fei Xiao, Guanhua Li, Changjiang Yu, Chengyu Jin, (unknown), Tucheng Sun, Ping Zhu	1
7	The epidemiology and prognosis of patients with primary gastric T‐cell lymphoma in the SEER program 2022 ·Cancer Medicine ·Minyue Zhang, Fei Xiao, Meisi Lin, Mengping Chen, Jian Hou, Honghui Huang	2
8	Hedgehog signaling reprograms hair follicle niche fibroblasts to a hyper-activated state 2022 ·Developmental Cell ·Yingzi Liu, Christian F. Guerrero‐Juarez, Fei Xiao, (unknown), Raúl Ramos, Chen‐Hsiang Kuan, Yuh‐Charn Lin, (unknown), Jung Min Park, Ji Won Oh, Ruiqi Liu, Sung‐Jan Lin, Marco Tartaglia, Ruey‐Bing Yang, Zhengquan Yu, Qing Nie, Ji Li, Maksim V. Plikus	49
9	Dissecting mutational allosteric effects in alkaline phosphatases associated with different Hypophosphatasia phenotypes: An integrative computational investigation 2022 ·PLoS Computational Biology ·Fei Xiao, (unknown), (unknown), (unknown), (unknown), Gennady M. Verkhivker, Guang Hu	8
10	Characteristics of the patellofemoral joint of patients with DDH and the effects of Bernese periacetabular osteotomy on the patellofemoral joint 2022 ·BMC Musculoskeletal Disorders ·Jianping Peng, Fei Xiao, (unknown), Chao Shen, Yang Li, (unknown), Yimin Cui, Xiaohong Chen	3
11	Network-Based Target Prioritization and Drug Candidate Identification for Multiple Sclerosis: From Analyzing “Omics Data” to Druggability Simulations 2021 ·ACS Chemical Neuroscience ·Yang Ji, Hongchun Li, Fan Wang, Fei Xiao, Wenying Yan, Guang Hu	6
12	Low Frequency of MKRN3 and DLK1 Variants in Chinese Children with Central Precocious Puberty 2019 ·International Journal of Endocrinology ·Ting Chen, Linqi Chen, Haiying Wu, (unknown), (unknown), Xiuli Chen, (unknown), Fei Xiao	10
13	Clinical, Genetics, and Bioinformatic Characterization of Mutations Affecting an Essential Region of PLS3 in Patients with BMND18 2018 ·International Journal of Endocrinology ·Ting Chen, Haiying Wu, (unknown), (unknown), Linqi Chen, (unknown), (unknown), Xiuli Chen, Huiting Zhou, (unknown), Fei Xiao	12
14	An atypical phenotype of a patient with infantile spinal muscular atrophy with respiratory distress type 1 (SMARD 1) 2018 ·European Journal of Medical Genetics ·Shuiyan Wu, Ting Chen, Ying Li, Linqi Chen, (unknown), Fei Xiao, Zhenjiang Bai	3
15	Interleukin 12B gene polymorphisms and susceptibility to rheumatoid arthritis: a data synthesis 2016 ·Clinical Rheumatology ·Xiaoqin Yang, Fei Xiao, Dan Luo, Guiping Wang, (unknown)	0
16	[Correlation of three common variation loci in von Willebrand factor gene and pulmonary thromboembolism disease]. 2015 ·PubMed ·(unknown), Xiaomao Xu, Liang Sun, (unknown), Zhenguo Zhai, (unknown), Fei Xiao	1
17	Dissection of hilar lymph node that was near left superior pulmonary vein 2015 ·ASVIDE ·Zhenrong Zhang, Deruo Liu, Yongqing Guo, (unknown), Fei Xiao, Qianli Ma, (unknown)	0
18	Dissection of interlobar lymph node surrounding the apical branch of left pulmonary artery 2015 ·ASVIDE ·Zhenrong Zhang, Deruo Liu, Yongqing Guo, (unknown), Fei Xiao, (unknown), (unknown)	0
19	Clinical characteristics and treatment of esophageal hemangioma: Analysis of 48 cases 2014 ·World Chinese Journal of Digestology ·Wen-Wen Liu, Fei Xiao, Lianzhen Yu, (unknown), Ruihua Shi, (unknown)	0
20	The mechanisms of palindrome-stimulated mutation and related human diseases 2013 ·Hereditas (Beijing) ·Xu Chen, Fei Xiao, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact